Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma

Even though tamoxifen has significantly improved the survival of estrogen receptor positive (ER+) mammary carcinoma (MC) patients, the development of drug resistance with consequent disease recurrence has limited its therapeutic efficacy. Trefoil factor-3 (TFF3) has been previously reported to media...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Guo, Hui [verfasserIn]

Tan, Yan Qin [verfasserIn]

Huang, Xiaoming [verfasserIn]

Zhang, Shuwei [verfasserIn]

Basappa, Basappa [verfasserIn]

Zhu, Tao [verfasserIn]

Pandey, Vijay [verfasserIn]

Lobie, Peter E. [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2023

Schlagwörter:

ER+ mammary carcinoma

Tamoxifen resistance

TFF3

Taxanes

AMPC

Übergeordnetes Werk:

Enthalten in: Cancer letters - Amsterdam [u.a.] : Elsevier Science, 1975, 579

Übergeordnetes Werk:

volume:579

DOI / URN:

10.1016/j.canlet.2023.216443

Katalog-ID:

ELV065782690

Nicht das Richtige dabei?

Schreiben Sie uns!